ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Educational Symposium

Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Kidney Disease

October 26, 2024 | 12:45 PM - 01:45 PM

Location: TBD, Marriott Marquis

Session Description

Agonists of the glucagon-like peptide-1 receptor (GLP1 RAs) are becoming an important player in diabetes itself, and in diabetic kidney disease for kidney and cardiovascular outcomes. Rapidly emerging data from randomized clinical trials offer a more and more granular view of the drugs' effectiveness and advance our understanding of their mechanism of action.

Support is provided by an educational grant from Novo Nordisk.

Learning Objective(s)

  • Outline recent advances in clinical trials of GLP1 RAs in diabetic kidney disease for kidney and cardiovascular outcomes
  • Describe the mechanisms of action of GLP1 RAs in diabetic complications

Learning Pathway(s)

  • Diabetic Kidney Disease
  • CKD Non-Dialysis

Moderator

Presentations